Our Mission
We advance global health by strengthening the quality, ethics, and reliability of clinical research.
Through independent oversight, regulatory inspection readiness, and targeted, knowledge-based capacity building, we empower organizations to establish sustainable, high-performing quality systems that protect patients and uphold scientific integrity.
Operating at the intersection of international standards and local practice, we collaborate with sponsors, CROs, and research sites to drive operational alignment, regulatory confidence, and continuous improvement — not merely compliance for inspection day.
Our approach fosters accountability, transparency, and excellence, enabling meaningful progress in clinical development and sustaining trust in the outcomes of scientific research.
Our Story
AMiK was founded by clinical quality and GCP audit specialists with extensive experience across Phase I–IV clinical trials in both pharmaceutical drug development and medical devices, including advanced therapies and complex, innovative modalities.
Our portfolio spans multinational, multicenter, and early-phase research programs across oncology, infectious diseases, immunology, neurology, rare conditions, and emerging therapeutic areas.
We have supported organizations through protocol development, trial execution oversight, quality system design, audit program leadership, and regulatory engagement with authorities such as EMA, FDA, MHRA, and national health agencies.
Our work goes beyond preparing teams for inspections.
We help organizations understand root causes, elevate internal decision-making, and establish sustainable quality practices that endure beyond a single audit or regulatory review.
We believe that trustworthy clinical evidence requires trustworthy research practices — documented, reliable, ethically grounded, and operationally aligned from the ground up.
Our leadership team brings hands-on experience in clinical research operations, GCP auditing, regulatory inspection readiness, CAPA development, TMF/eTMF oversight, and vendor/sponsor quality governance.
We have guided organizations through protocol startup, trial execution oversight, audit readiness, and interactions with regulatory authorities such as EMA, FDA, MHRA, WHO, and national health agencies.
What defines our approach is a focus on:
-
Clarity in expectations and documentation
-
Capability-building rather than dependency
-
Knowledge transfer that strengthens teams long-term
We collaborate with research organizations to build mature, high-performing quality systems that support ethical conduct, participant protection, and meaningful scientific outcomes — not just compliance for inspection day
